IL 31 Mechanism of Action and Clinical Implications for Prurigo Nodularis
Автор: LiVDerm: Revolutionizing Dermatology Education
Загружено: 2024-11-26
Просмотров: 1026
Описание:
This is the second episode of a two-part miniseries, "IL-31 Inhibition for Treatment of Prurigo Nodularis" series, supported by an educational grant from Galderma. Hosted by expert dermatologist and neuroscientist Dr. Sarina Elmariah, MD, PhD, MPH, this episode, "IL-31 Mechanism and Clinical Implications for PN", featuring Dr. Shawn Kwatra, discusses the following topics:
• Mechanism of action for IL-31 inhibitor nemolizumab
• Clinical safety and efficacy data for nemolizumab for treatment of PN
• Strategies for prescribing IL-31 inhibitors in clinical practice
• Pearls for patient selection and addressing treatment challenges
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
